In: Accounting
PSI, Inc.’s financial executives have been arguing about the proper way to record the patent they acquired four (4) years ago. The patent was originally purchased for $212,500. At the time of the purchase, PSI’s management believed that the patent would benefit the company for 10 years, after which is would be worthless. Using this information, they have amortized the patent to its current value of $127,500, which is currently shown on the company’s Balance Sheet.After attending a recent conference, the CFO determined that the current market value of the patent is only $115,000, not the full $127,500. Since PSI is having a good year this year, she
Select an area to comment on
3 / 3
solution : As per IAS 36 -"IMPAIRMENT OF ASSETS" impairment means reduction in carrying value{CA} of assets upto its recoverable amount{RA}
so impairmrnt loss = CA -RA
RA is calculated as follows
RA is lower of
1. value in use (entity specific value)
2. fair value - coat to disposal (market specific value)
to check impairment loss at every repaorting period we have to conduct impaiement test at enf of reporting period .
imapirment loss shall be chargeed to Ravaluation Reserve (1st preferance) or Profit and loss account if entity does not have Ravaluation Reserve
solution 1 : as per explaantion above RA is upto lower of value in use or fv less ctd
here given that market value of patent is$ 115,000 so this is the FV less CTD (Market Specific value).
we dont have value in use hence RA = 115,000
so impairment loss = CA - RA
= $127,500 - $115,000
= $12500
solution 2:
journal entry :A) if entity have REvalution Reserve
impairment loss on patent ........$12500
to Revalution Reserve..........................$12500
b) if entity not have Revalution reserve
impairment loss on patent ........$12500
to profit and loss a/c..........................$12500
solution 3 : there are market indicators that market value of patent is redcued so company habe book impairment loss for the year .
(if you have any query related to this just ask me)